Fluconazole dosages greater than 800 mg day-1 have been reported in about 900 patients treated for candidemia, oropharyngeal candidiasis and cryptococcal meningitis in HIV-infected patients, and for initial therapy of endemic mycoses. In patients with life-threatening infections caused by Candida spp., Cryptococcus neoformans and Coccidioides immitis, results of a limited number of dose-finding trials with non-neutropenic and HIV-infected patients show dose-dependent responses. These study results indicate that higher daily doses of fluconazole than are currently approved for these indications are well tolerated and tend to provide better clinical efficacy in selected patient populations. An excellent safety profile of dosages up to 2000 mg day-1 and linear predictable pharmacokinetics up to 1600 mg day-1 appear to justify further clinical investigations to better determine the optimum dosage and duration of treatment.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1439-0507.1997.tb00231.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[The effect of concentrated growth factor on the biological performance of human dental pulp stem cells under oxidative stress status].
Zhonghua Kou Qiang Yi Xue Za Zhi
January 2025
Department of Stomatology, Renmin Hospital, Hubei University of Medicine, Shiyan 442000, China.
To investigate the effect of concentrated growth factor (CGF) on the biological performance of human dental pulp stem cells (hDPSCs) under oxidative stress status induced by hydrogen peroxide (HO). The hDPSCs were isolated by using tissue block separation method from healthy permanent teeth extracted for orthodontic reason. hDPSCs surface markers CD34, CD45, CD90 and CD105 were detected by flow cytometry.
View Article and Find Full Text PDFCannabis use characteristics and associations with problematic use outcomes, quitting-related factors, and mental health among US young adults.
Subst Abuse Treat Prev Policy
January 2025
Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.
Objective: Given the changes in trends of cannabis use (e.g., product types), this study examined latent classes of young adult use and associations with use-related outcomes.
View Article and Find Full Text PDFPutative biomarkers of hepatic dysfunction in critically ill sepsis patients.
Clin Exp Med
January 2025
Pediatrics, Western University, London, ON, Canada.
Sepsis is a major cause of morbidity and mortality worldwide. Among the various types of end-organ damage associated with sepsis, hepatic injury is linked to significantly higher mortality rates compared to dysfunction in other organ systems. This study aimed to investigate potential biomarkers of hepatic injury in sepsis patients through a multi-center, case-control approach.
View Article and Find Full Text PDFInfluence of diet nutrient density and a multicarbohydrase containing α-galactosidase on performance, carcass characteristics, breast myopathies, and nutrient utilization of broilers reared from 1 to 42 days of age.
Poult Sci
January 2025
Department of Poultry Science, Auburn University, 260 Lem Morrison Dr., Auburn, AL 36849, USA. Electronic address:
Article Synopsis
- - This study examined how nutrient density and adding an enzyme (CAG) affect the growth and health of broiler chickens from 1 to 42 days old, using 1,800 male broilers across six different diet treatments.
- - The experiment involved three different diet formulations varying in metabolizable energy (ME) and amino acid (AA) density, with some groups receiving the enzyme supplement and others not.
- - Results showed that the enzyme improved feed efficiency, nutrient digestibility, and overall performance, particularly in birds fed lower nutrient diets, pointing to the benefits of CAG supplementation in poultry nutrition.
Comparison of the Effects of Mucosa Tissue Healing with Chlorhexidine Digluconate and Choline Salicylate in Patients Wearing a Removable Prosthetic Restoration-A RCT.
Clin Pract
November 2024
Department of Temporomandibular Disorders, Medical University of Silesia in Katowice, Traugutta Sq. 2, 41-800 Zabrze, Poland.
Article Synopsis
- A clinical trial was conducted to evaluate the effectiveness of 0.2% chlorhexidine digluconate (CHX) and 8.7% choline salicylate (CHS) in healing oral mucosa lesions in patients receiving new partial removable dentures (PRDs) compared to a control group with no treatment.
- Twenty-seven healthy patients participated, and the healing progress was monitored through measurable wound surface area (WSA) over 14 days using intraoral images.
- Results showed that CHX led to the quickest reduction in WSA after 7 days (85.1%), followed by CHS after 10 days (70.1%) and the control group after 14 days (59.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!